- Michael R. Bloomberg reappointed as WHO Global Ambassador of Noncommunicable Diseases and Injuries
- New Gallup survey indicates strong global support for policies outlined in WHO report to combat growing public health burden of noncommunicable diseases
Today, Dr Tedros Adhanom Ghebreyesus, Director-General of WHO, launched a new report calling on global leaders to take urgent action on noncommunicable diseases (NCDs), responsible for 17 million premature deaths every year.
To accelerate action Dr Tedros renewed the two-year appointment of Michael R. Bloomberg as WHO Global Ambassador for Noncommunicable Diseases and Injuries. This is Bloomberg’s third reappointment as Ambassador, having first been appointed to the role in 2016.
The announcement came at the first annual gathering of a Heads of State and Government Group for the Prevention of NCDs, led by the President of Ghana and the Prime Minister of Norway, held during the 77th Session of the United Nations General Assembly (UNGA). This follows the launch of a earlier this year by Ghana and Norway.
To mark the occasion, WHO released a new report, “,” and a that for the first time, brings together all WHO data related to NCDs for 194 countries. The report and portal highlight the extent of global NCD burden, risk factors, and the progress each country is making in their efforts to combat these diseases and conditions. Every two seconds, someone under 70 somewhere in the world dies of an NCD. Noncommunicable diseases like heart disease, cancer, diabetes, and lung disease now outnumber infectious disease as the top killers globally.
“This report is a reminder of the true scale of the threat posed by NCDs and their risk factors,” said Dr Tedros. “There are cost-effective and globally applicable NCD interventions that every country, no matter its income level, can and should be using and benefitting from – saving lives and saving money. I thank President Afuko-Addo, Prime Minister Støre and Michael Bloomberg for their leadership and vision in addressing this major global health issue.”
Bloomberg’s reappointment comes at a critical juncture for public health. During the COVID-19 pandemic, people living with NCDs faced worse outcomes than those without. Today, commissioned by WHO and Bloomberg Philanthropies that found most respondents in five surveyed countries – including Colombia, India, Jordan, the United Republic of Tanzania and the United States of America rank an NCD or NCD risk factor as the biggest health problem in their country.
Yet, the majority of people surveyed across all countries support a wide number of proven interventions and policies that can reduce deaths from NCDs, such as incorporating more green spaces in urban health design and increasing taxes on tobacco.
“As we continue to respond to this pandemic and prepare for the next, we have seen the critical importance of addressing a major risk factor in COVID-19 hospitalizations and deaths – noncommunicable diseases,” said Michael R. Bloomberg, Founder of Bloomberg Philanthropies and WHO Global Ambassador for Noncommunicable Diseases and Injuries. “Noncommunicable diseases such as cardiovascular disease, diabetes, chronic lung disease, and cancer are the world’s biggest silent killers – but they can often be prevented with investment in proven, cost-effective interventions. I look forward to continuing to make life-saving investments in NCD and injury prevention alongside Dr Tedros and the WHO.”
As WHO Global Ambassador, Bloomberg will continue to support global, national, and local efforts to protect people from NCDs and injuries. This work also advances the 2030 UN Sustainable Development Goal (SDG 3.4) target to reduce the global number of NCD deaths by one-third through high-impact, population-level policies and programmes implemented in cities across the world.
NCDs cause nearly three-quarters of deaths worldwide. Every year, 17 million people under the age of 70 die of NCDs, 86 percent of whom live in low- and middle-income countries. The COVID-19 pandemic further exacerbated the NCD burden by delaying and disrupting care, and in the early months of the pandemic, 75 percent of countries reported disruption to essential NCD services because of lockdown restrictions and channelling of resources. While every Member State of the United Nations has committed to reducing premature death from NCDs by one-third by 2030 – an effort that could save millions of lives – few countries are currently on track to achieve it. Urgent global efforts are needed to get back on track to reach Sustainable Development Goal targets and reduce premature deaths from NCDs.
About the World Health Organization
The World Health Organization provides global leadership in public health within the United Nations system. Founded in 1948, WHO works with 194 Member States, across six regions and from more than 150 offices, to promote health, keep the world safe and serve the vulnerable. By connecting countries, people and partners, we strive to give everyone, everywhere an equal chance at a safe and healthy life.
About Michael Bloomberg’s work in public health
An international leader on public health issues, Bloomberg’s investments in public health include major, life-saving initiatives to reduce tobacco and youth e-cigarette use through over , support healthy food policy, reduce drowning, and improve road safety and maternal health, among others. In 2016, he launched the at Johns Hopkins University to tackle declining life expectancy in the United States, and in 2017, started the , a global network of 70 cities committed to reducing noncommunicable diseases and injuries. Recently, Bloomberg Philanthropies in global public health nonprofit Resolve to Save Lives – bringing its total investment to $215 million – to continue preventing deaths from heart disease.
About Bloomberg Philanthropies
Bloomberg Philanthropies invests in 941 cities and 173 countries around the world to ensure better, longer lives for the greatest number of people. The organization focuses on five key areas for creating lasting change: the Arts, Education, Environment, Government Innovation, and Public Health.
